Status:
UNKNOWN
MicroPort® Endoscopic Instrument Control System to Accomplish Robotic-assisted Surgery in Urology
Lead Sponsor:
Changhai Hospital
Conditions:
Robotic Surgical Procedures
Prostatectomy
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Laparoscopy, now virtually completely, was replaced with robotic surgery in uro-oncological surgery in the world. And given the significant increase in the number of robotic surgeries for prostate, bl...
Eligibility Criteria
Inclusion
- be aged between 18 years and 80 years;
- laparoscopic surgery is required with one of the following surgical indications:(1)planning to perform radical prostatectomy(clinical stage is T1 or T2,and PSA≥ 0.2ng/mL) ;(2) planning to perform nephrectomy
- being able to cooperate and complete the follow-up and related examinations;
- volunteer to participate in this study and sign the informed consent.
Exclusion
- patients requiring emergency surgery;
- have severe cardiovascular or circulatory disease and cannot tolerate surgery;
- participated in other clinical trials in the last 3 months;
- failure to understand study requirements
Key Trial Info
Start Date :
June 29 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2022
Estimated Enrollment :
104 Patients enrolled
Trial Details
Trial ID
NCT04404738
Start Date
June 29 2020
End Date
December 1 2022
Last Update
September 1 2020
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine
Shanghai, China
2
The first affiliated hospital of naval medical university (Shanghai changhai hospital)
Shanghai, China
3
Zhongshan Hospital Affiliated to Fudan University
Shanghai, China
4
Zhejiang Provincial People's Hospital
Zhejiang, China